Work

High Molecular Risk Mutations (HMR) Drive Progression of CALR-mutated Myeloproliferative Neoplasm (MPN)

Year: 2024

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2024-194860

Authors: Resham Mawalkar, Hua-Ling Tsai, Terra Marie M Jouaneh, Shivam Patel, Christopher Gocke, Eitan Halper-Stromberg, Rena R. Xian, K. C. Rappazzo, Evan M. Braunstein, Alison R. Moliterno, Tania Jain

Institutions: Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medicine

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4405034784

Cites:

Cited by:

Related to: 10